Long-Term Clinical Benefits of Canagliflozin 100 mg Versus Sulfonylurea in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin in India-Reference-Cited by-同舟云学术

Long-Term Clinical Benefits of Canagliflozin 100 mg Versus Sulfonylurea in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin in India

Published:2019-05 Issue: Volume:18 Page:65-73
ISSN:2212-1099
Container-title:Value in Health Regional Issues
language:en
Short-container-title:Value in Health Regional Issues

Author:

Gupta Vishal,Willis Michael,Johansen Pierre,Nilsson Andreas,Shah Manan,Mane Amey,Neslusan Cheryl

Publisher

Elsevier BV

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Reference71 articles.

1. IDF Diabetes Atlas,2015

2. The current state of diabetes mellitus in India;Kaveeshwar;Australas Med J,2014

3. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study;Anjana;Lancet Diabetes Endocrinol,2017

4. The economic burden of diabetes in India: a review of the literature;Yesudian;Global Health,2014

5. Economic burden of diabetes;Singh,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of dapagliflozin on life expectancy in type 2 diabetes mellitus patients in routine practice;Diabetes mellitus;2023-07-07

2. Type II diabetes mellitus: a review on recent drug based therapeutics;Biomedicine & Pharmacotherapy;2020-11

3. Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes in the UK;Advances in Therapy;2020-04-18

4. Oral health-related quality of life in well-controlled diabetic patients of Modinagar city: A cross-sectional study;Journal of Indian Association of Public Health Dentistry;2020